This cost-effective treatment option is the only carbon neutral beclometasone pMDI available in the UK . Slough, UK, June 20 th 2023: Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin ...

GPs are being advised to review their asthma patients' prescriptions after drug firm Teva said the inhaler Beclazone would no longer be available. The company wrote to all GPs and healthcare ...

Single-inhaler triple therapy with the extra-fine formulation of beclometasone, formoterol fumarate and glycopyrronium was cost-effective in adults with uncontrolled asthma, researchers reported ...

Trimbow is the first fixed triple combination as extrafine formulation in a single inhaler that can improve adherence to the therapy. CHMP positive opinion is based on data obtained in 12 clinical ...

3.2 Beclometasone dipropionate is licensed for use in children in 10 different products. Three of these products are press-and-breathe pMDIs using a CFC propellant ... The costs also vary depending on ...

A fixed-dose combination of the ICS beclometasone dipropionate (BDP) and LABA formoterol fumarate (FF) has been recently approved in Europe for the treatment of COPD.

CHF 5993 and Trydonis, from Chiesi Farmaceutici SpA, combine a glucocorticoid, a long-acting beta-2 receptor agonist, and a long-acting muscarinic antagonist.

The EMA's CHMP has recommended granting marketing authorization for Trimbow, a combination of three inhaled medications, for the maintenance treatment of adults with moderate to severe COPD.

Slough, UK, June 20 th 2023: Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin) has announced the UK launch of Beclu ® (beclometasone dipropionate) 100 micrograms (mcg) ...